Vitamin B6 is found in foods like meat, dairy, and chickpeas. The body uses vitamin B6 to make cells for blood flow and brain function. Vitamin B6 has been used to ease migraine pain and morning sickness in pregnancy. It has also been used to improve symptoms of depression and menstruation. It is also used to manage Vitamin B6 deficiency. Vitamin B6 can be taken as a pill. It can also be injected into the bloodstream or muscle by a healthcare provider.
100 milligrams per day
What Research Shows
May Be Effective
Unlikely to Be Effective
Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.
It is likely safe to take vitamin B6 in small doses for a short time. High doses may not be safe. Not enough studies have been done to say whether it is safe to take for a long period. Women who are pregnant or breastfeeding should not take large doses of vitamin B6.
Talk to your doctor about any supplements or therapy you would like to use. Some can interfere with treatment or make conditions worse such as:
A. Atopic Eczema
A1. Bath-Hextall FJ, Jenkinson C, et al. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005205.
B. Cancer Treatment Support
B1. Chen M, Zhang L, Wang Q, Shen J. Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review. PLoS One. 2013 Aug 20;8(8):e72245.
B2. Jo SJ, Shin H, et al. Prophylactic and therapeutic efficacy of pyridoxine supplements in the management of hand-foot syndrome during chemotherapy: a meta-analysis. Clin Exp Dermatol. 2015;40(3):260-270.
B3. Huang XZ, Chen Y, et al. Clinical evidence of prevention strategies for capecitabine-induced hand-foot syndrome. Int J Cancer. 2018 Jun 15;142(12):2567-2577.
C. Coronary Revascularization
C1. Qin X, Fan F, et al. Folic acid supplementation with and without vitamin B6 and revascularization risk: a meta-analysis of randomized controlled trials. Clin Nutr. 2014 Aug;33(4):603-612.
D. Hyperemesis Gravidarum
D1. Boelig RC, Barton SJ, et al. Interventions for treating hyperemesis gravidarum. Cochrane Database Syst Rev. 2016 May 11;(5):CD010607.
D2. Boelig RC, Barton SJ, et al. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2018 Sep;31(18):2492-2505.
E. Labor Support
E1. Salam RA, Zuberi NF, et al. Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes. Cochrane Database Syst Rev. 2015;(6):CD000179.
F1. Askari G, Nasiri M, et al. The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized, placebo-controlled, clinical trial. Nutrition. 2017;38:74-79.
G. Pregnancy Support
G1. Dror DK, Allen LH. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr Perinat Epidemiol. 2012 Jul;26 Suppl 1:55-74.
G2. Koren G, Clark S, et al. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. BMC Pregnancy Childbirth. 2015;15:59.
G3. Matthews A, Haas DM, et al. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015 Sep 8;(9):CD007575.
G4. Koren G, Clark S, et al. Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. BMC Pregnancy Childbirth. 2016;16(1):371.
G5. Sridharan K, Sivaramakrishnan G. Interventions for treating nausea and vomiting in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. Expert Rev Clin Pharmacol. 2018 Nov;11(11):1143-1150.
H1. Dong H, Pi F, et al. Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials. PLoS One. 2015 Sep 10;10(9):e0137533.
I. Suppression of Lactation
I1. Oladapo OT, Fawole B. Treatments for suppression of lactation. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005937.
J. Tardive Dyskinesia
J1. Adelufosi AO, Abayomi O, et al. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2015 Apr 13;(4):CD010501.
Last reviewed July 2019 by EBSCO NAT Review Board Eric Hurwitz, DC
Last Updated: 3/26/2020
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.